1. Home
  2. TSHA vs BOBS Comparison

TSHA vs BOBS Comparison

Compare TSHA & BOBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taysha Gene Therapies Inc.

TSHA

Taysha Gene Therapies Inc.

HOLD

Current Price

$5.66

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Bob's Discount Furniture Inc. Common Stock

BOBS

Bob's Discount Furniture Inc. Common Stock

N/A

Current Price

$15.53

Market Cap

2.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
TSHA
BOBS
Founded
2019
1991
Country
United States
United States
Employees
N/A
5950
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
TSHA
BOBS
Price
$5.66
$15.53
Analyst Decision
Strong Buy
Buy
Analyst Count
8
11
Target Price
$11.63
$23.73
AVG Volume (30 Days)
4.1M
1.0M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
5.56
N/A
EPS
N/A
N/A
Revenue
$9,773,000.00
N/A
Revenue This Year
N/A
$12.58
Revenue Next Year
$1,152.42
$7.43
P/E Ratio
N/A
$18.67
Revenue Growth
17.28
N/A
52 Week Low
$2.53
$9.74
52 Week High
$7.30
$23.11

Technical Indicators

Market Signals
Indicator
TSHA
BOBS
Relative Strength Index (RSI) 43.52 53.30
Support Level $5.28 $14.33
Resistance Level $6.01 $16.70
Average True Range (ATR) 0.45 0.92
MACD -0.10 -0.08
Stochastic Oscillator 24.09 41.41

Price Performance

Historical Comparison
TSHA
BOBS

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS. The company's clinical program TSHA-102 is in development for the treatment of Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. The Company views its operations and manages its business as a single operating segment, the gene therapy segment, which is the business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the central nervous system.

About BOBS Bob's Discount Furniture Inc. Common Stock

Bobs Discount Furniture Inc operates as a furniture retailer offering a wide variety of merchandise assortments across several categories, including upholstery, case goods, bedding, and other. The company generates the majority of its revenue from the sale of its products through its retail stores.

Share on Social Networks: